Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes von Patnaik, M M, Padron, E, LaBorde, R R, Lasho, T L, Finke, C M, Hanson, C A, Hodnefield, J M, Knudson, R A, Ketterling, R P, Al-kali, A, Pardanani, A, Ali, N A, Komroji, R S, Tefferi, A

Volltext